Reading Room Production — page 235

From: "Stemmy, Erik (NIH/NIAID) [E]" </O=EXCHANGELABS/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=585133D3FA194F06AA618678B2817C22STEMMYEJ> To: "Linde, Emily (NIH/NIAID) [E]" < @mail.nih.gov>, "Sanders, Ashley (NIH/OD) [E]" < @nih.gov> Cc: "Shannon, Mike (NIH/OD) [E]" < @nih.gov> Subject: RE: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Date: Thu, 21 May 2020 11:22:11 -0400 Importance: Normal Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18 Bethesda, MD 20892-9825 Phone: Email: @nih.gov From: Linde, Emily (NIH/NIAID) [E] @mail.nih.gov> Sent: Thursday, May 21, 2020 6:17 AM To: Sanders, Ashley (NIH/OD) [E] @nih.gov> Cc: Shannon, Mike (NIH/OD) [E] @nih.gov>; Stemmy, Erik (NIH/NIAID) [E] @nih.gov> Subject: RE: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily From: Sanders, Ashley (NIH/OD) [E] @nih.gov> Sent: Wednesday, May 20, 2020 1:00 PM To: Linde, Emily (NIH/NIAID) [E] @mail.nih.gov> Cc: Shannon, Mike (NIH/OD) [E] @nih.gov> Subject: RE: Grant Questions - FBI Inquiry - 1-R01AI110964-01 - 2-R01AI110964-06 Importance: High